Cutler Group LP Alector, Inc. Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$5.85 - $9.84 $503 - $846	86 New	86 $0
Q3 2022 Oct 25, 2022	SELL	$8.19 - $13.2 $3,439 - $5,544	-420 Reduced 29.58%	1,000 $9,000
Q2 2022 Aug 04, 2022	SELL	$7.65 - $14.24 $5,286 - $9,839	-691 Reduced 32.73%	1,420 $14,000
Q1 2022 Apr 14, 2022	SELL	$13.02 - $20.78 $27,342 - $43,638	-2,100 Reduced 49.87%	2,111 $30,000
Q4 2021 Jan 18, 2022	SELL	$19.35 - $25.54 $48,375 - $63,850	-2,500 Reduced 37.25%	4,211 $86,000
Q3 2021 Oct 26, 2021	BUY	$21.65 - $39.49 $108,488 - $197,884	5,011 Added 294.76%	6,711 $153,000
Q1 2021 Apr 26, 2021	SELL	$14.84 - $22.23 $26,712 - $40,014	-1,800 Reduced 51.43%	1,700 $34,000
Q4 2020 Jan 21, 2021	BUY	$9.4 - $16.7 $15,980 - $28,390	1,700 Added 94.44%	3,500 $52,000
Q3 2020 Oct 27, 2020	BUY	$10.54 - $24.96 $18,972 - $44,928	1,800 New	1,800 $18,000

165

58.1M

57K

14.9K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $376M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.